Sigurd D. Süßmuth - Concepedia

Author

Sigurd D. Süßmuth

Also Known As

Claudia Cormio, Daniela Schwenk, S D Süssmuth, S Süssmuth, S. D. Süßmuth, S. D. Süssmuth, S. Sussmuth, S. Süßmuth, S. Süssmuth, S.D Süssmuth

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Universität Ulm University College London Heidelberg University University of St Andrews Leiden University Medical Center

About

Sigurd D. Süßmuth is an author at Universität Ulm specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	792
2	Social Sciences	10	10	472
3	Health Sciences	2	2	112
4	Arts	1	1	18
5	Engineering	1	1	21

Sigurd D. Süßmuth

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Aggregation Substance Promotes Adherence, Phagocytosis, and Intracellular Survival of<i>Enterococcus faecalis</i>within Human Macrophages and Suppresses Respiratory Burst Sigurd D. Süßmuth, Albrecht Muscholl‐Silberhorn, Reinhard Wirth, Infection and Immunity DysbiosisAggregation SubstanceMicrobial PathogensSex Pheromone PlasmidsImmunology	2000	194
An exploratory double‐blind, randomized clinical trial with selisistat, a <scp>SirT1</scp> inhibitor, in patients with <scp>H</scp>untington's disease Sigurd D. Süßmuth, Salman Haider, G. Bernhard Landwehrmeyer, British Journal of Clinical Pharmacology	2014	161
Tau protein in cerebrospinal fluid (CSF): a blood–CSF barrier related evaluation in patients with various neurological diseases Sigurd D. Süßmuth, Hansotto Reiber, Hayrettin Tumani Neuroscience Letters Neurodegenerative DiseasesNeurobiology Of DiseaseMedicineCerebrospinal FluidNeurochemical Biomarkers	2001	102
Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum Sigurd D. Süßmuth, Hayrettin Tumani, Daniel Ecker, Neuroscience Letters Neurodegenerative DiseasesAmyotrophic Lateral SclerosisProteinopathiesPathologyDegenerative Disease	2003	96
Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases Sarah Jesse, Johannes Brettschneider, Sigurd D. Süßmuth, Journal of Neurology Neurological DisorderNeurochemical BiomarkersCsf Routine ParametersAlzheimer's DiseaseCerebrospinal Fluid	2010	80
A randomized, placebo‐controlled trial of AFQ056 for the treatment of chorea in Huntington's disease Ralf Reilmann, Marie‐Laure Rouzade‐Dominguez, Carsten Saft, Movement Disorders	2015	78
Neurofilament heavy‐chain NfH<sup>SMI35</sup> in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes Johannes Brettschneider, Axel Petzold, Sigurd D. Süßmuth, Movement Disorders	2006	70
The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation Yuri Milaneschi, Kelly A. Allers, Aartjan T.F. Beekman, Brain Behavior and Immunity	2021	67
A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises Stefan S. Schönsteiner, Heidi Bauder Mißbach, Axel Benner, Experimental Hematology and Oncology	2017	62
Visual system integrity and cognition in early Huntington's disease Robert Christian Wolf, Fabio Sambataro, Nenad Vasić, European Journal of Neuroscience NeuropsychologyBrain FunctionBrain MappingSocial SciencesNeurological Functioning	2014	47

Page 1